NuVasive Inc. (NUVA) Shares Slip, Investors Watching Closely, Here is Why

Zacks Investment Research (NuVasive Inc.: NASDAQ) shares fell on Wednesday Dec 28 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Zacks Investment Research downgraded shares of Zacks Investment Research (NuVasive Inc.: NASDAQ) from Hold to Sell in a research note to investors today. Zacks Investment Research currently has a rating of Sell on the stock. The one-year price target of $71.71 is higher than the opening price of $66.34, causing a number of other analysts to comment on the stock in recent days. Looking back over the last year, NuVasive Inc. stock has a high of $69.50. Downgrades are more common when analysts consider that the future prospects for the security have diminished from the initial recommendation, often due to an important and fundamental digression in the company’s actions, future vision or industry.

Zacks Investment Research (NuVasive Inc.: NASDAQ) shares last traded at $66.32, a dip of $0.41 per share or -0.61% compared to the previous closing price. Opening at $66.34, they varied from $66.32 and $66.82 throughout the day.

Zacks Investment Research (NuVasive Inc.: NASDAQ) currently has a market cap of 3.34B.

Zacks Investment Research (NuVasive Inc.: NASDAQ) Average Daily Trading Volume

The stock’s average daily volume is 721,133 shares out of a total float 49,459,000 and some 13,905 shares traded hands yesterday, lower than the average. Momentum traders often use increases in trading volume to pinpoint substantial volume accumulation or distribution by institutional investors, so look for trading volume to pick up in the coming days.

While an increase in trading for short periods will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive indicator to market traders that institutions may be moving in, so institutional sponsorship is critical.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts that investigate thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

Zacks Investment Research (NuVasive Inc.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

Traders can make more effective judgments on trades when they follow the trading habits of professional investors.

With that in mind, Zacks Investment Research (NuVasive Inc.: NASDAQ) now has a 50-day MA of $64.65 and 200-day MA of $63.42. It has traded in a 52-week range between $36.81 – 69.50 and today’s last price is 4.58%% lower than the 52 week high of $69.50.

Earnings growth is a crucial factor to consider when buying stocks and investors identify companies that have been successful at growing their earnings by at least 25% for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *